Download video

Convalescent plasma clinical trial with Mayo Clinic

815 views

CoxHealth

5 years ago

Convalescent plasma clinical trial with Mayo Clinic

Convalescent plasma clinical trial with Mayo Clinic

SARS2 coronavirus immunity, re-infection and convalescent plasma as treatment for COVID-19 (#9)
8:57
SARS2 coronavirus immunity, re-infection and convalescent plasma as treatment for COVID-19 (#9)
by Diaries of a coronavirologist
Convalescent Plasma: Recommendations for Physicians Treating Patients with COVID-19, Part 2
12:46
Convalescent Plasma: Recommendations for Physicians Treating Patients with COVID-19, Part 2
by aabbmedia
CCRN Neurology Practice Questions Part 2
9:02
CCRN Neurology Practice Questions Part 2
by Lifelong Nursing
Real-world efficacy of second-line cabozantinib in renal cell carcinoma
0:40
Real-world efficacy of second-line cabozantinib in renal cell carcinoma
by VJOncology
Results of a Phase I study of sonrotoclax for the treatment of R\/R Waldenström’s macroglobulinemia
1:19
Results of a Phase I study of sonrotoclax for the treatment of R\/R Waldenström’s macroglobulinemia
by VJHemOnc – Video Journal of Hematology \& HemOnc
Real-world outcomes of 2L carboplatin and pemetrexed in EGFRm NSCLC
0:56
Real-world outcomes of 2L carboplatin and pemetrexed in EGFRm NSCLC
by VJOncology
Azacitidine, venetoclax \& magrolimab in patients with newly diagnosed \& R\/R high-risk AML
4:10
Azacitidine, venetoclax \& magrolimab in patients with newly diagnosed \& R\/R high-risk AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Navient 2D C-arm navigation for Spine surgery
0:47
Navient 2D C-arm navigation for Spine surgery
by ClaroNav Kolahi Inc.
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
4:27
A Phase II trial of venetoclax and cytarabine with or without midostaurin in older patients with AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Using uMRD Can Guide Venetoclax Duration in CLL - Dr. Brian Koffman
7:11
Using uMRD Can Guide Venetoclax Duration in CLL - Dr. Brian Koffman
by CLL Society
The Role of Ivabradine as a POTS Treatment Option (Corlanor)
6:58
The Role of Ivabradine as a POTS Treatment Option (Corlanor)
by Dr. Nathan Keiser
Carboplatin \& Pemetrexed: Chemotherapy Treatment for Lung Cancer - What You Need to Know
1:29
Carboplatin \& Pemetrexed: Chemotherapy Treatment for Lung Cancer - What You Need to Know
by ONCO EMPATH
LenCabo: lenvatinib + everolimus improves PFS over cabozantinib in metastatic ccRCC
2:41
LenCabo: lenvatinib + everolimus improves PFS over cabozantinib in metastatic ccRCC
by VJOncology
Phase Ib\/II trial of 177Lu-girentuximab with cabozantinib and nivolumab in clear cell RCC
0:54
Phase Ib\/II trial of 177Lu-girentuximab with cabozantinib and nivolumab in clear cell RCC
by VJOncology
CACLP 2025 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
2:19
CACLP 2025 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
by CACLP
Treatment options for elderly CLL patients or those with comorbidities beyond BCL2 inhibitors
0:59
Treatment options for elderly CLL patients or those with comorbidities beyond BCL2 inhibitors
by VJHemOnc – Video Journal of Hematology \& HemOnc
RESONATE-2: ibrutinib and chlorambucil for frontline CLL
2:56
RESONATE-2: ibrutinib and chlorambucil for frontline CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Interim analysis of a Phase II study of pirtobrutinib + venetoclax in previously treated WM
2:25
Interim analysis of a Phase II study of pirtobrutinib + venetoclax in previously treated WM
by VJHemOnc – Video Journal of Hematology \& HemOnc
Optimizing the combination of ibrutinib plus venetoclax in CLL
2:46
Optimizing the combination of ibrutinib plus venetoclax in CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Obinutuzumab, ibrutinib, and venetoclax in high-risk CLL: the CLL2-GIVe and CLL13 trials
2:00
Obinutuzumab, ibrutinib, and venetoclax in high-risk CLL: the CLL2-GIVe and CLL13 trials
by VJHemOnc – Video Journal of Hematology \& HemOnc
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
0:55
EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer
by VJOncology
Results from a Phase II trial of pirtobrutinib, venetoclax, and obinutuzumab in CLL
1:43
Results from a Phase II trial of pirtobrutinib, venetoclax, and obinutuzumab in CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
How much convalescent plasma do Arizona hospitals have?
2:29
How much convalescent plasma do Arizona hospitals have?
by Arizona’s Family (3TV \/ CBS 5)